Zobrazeno 1 - 4
of 4
pro vyhledávání: '"John Coatney"'
Autor:
Mohammed Saeed, Raymond Y. Yeow, Teetouch Ananwattanasuk, Frank Pelosi, Aman Chugh, Eugene H. Chung, Hakan Oral, Ghanshyam Palamaner Subash Shantha, John Coatney, Thomas Crawford, Rakesh Latchamsetty, Hamid Ghanbari, Krit Jongnarangsin, Sina Jame, Michael Ghannam, Frank Bogun, Tom Cascino, Ryan Cunnane
Publikováno v:
Pacing and clinical electrophysiology : PACEREFERENCES. 43(8)
BACKGROUND Implanted defibrillators are capable of recording activity data based on company-specific proprietary algorithms. This study aimed to determine the prognostic significance of baseline and decline in device-derived activity level across dif
Autor:
Hakan Oral, Hamid Ghanbari, Shikha Sharma, Konstantinos Kossidas, Auras R. Atreya, Aman Chugh, Miki Yokokawa, Patrick Dillon, Ryan Cunnane, Rakesh Latchamsetty, Krit Jongnarangsin, Michael Ghannam, Mohammed Saeed, Frank Bogun, Daniel Alyesh, Fred Morady, Frank Pelosi, Thomas Crawford, John Coatney
Publikováno v:
Heart rhythm. 15(11)
There are no randomized controlled studies of the efficacy and safety of protamine to reverse anticoagulant effects of heparin after catheter ablation (CA) of atrial fibrillation (AF).The purpose of this study was to determine the efficacy and safety
Autor:
Rakesh Latchamsetty, Thomas Cascino, Frank Pelosi, John Coatney, Michael Ghannam, Hakan Oral, Eugene H. Chung, Frank Bogun, Hamid Ghanbari, Krit Jongnarangsin, Mohammed Saeed, Sina Jame, Aman Chugh, Ghanshyam Palamaner Subash Shantha, Teetouch Ananwattanasuk, Ryan Cunnane, Raymond Y. Yeow
Publikováno v:
Journal of the American College of Cardiology. 73:312
Autor:
John Fanikos, Samuel Z. Goldhaber, Gregory Piazza, Michael Ehle, John Coatney, Julie K. Atay, Geoffrey D. Barnes, James B. Froehlich
Publikováno v:
The American Journal of Cardiology. 112:387-389
Dabigatran was expected to replace warfarin for stroke prevention in patients with nonvalvular atrial fibrillation (AF) who are warfarin naive, difficult to maintain in therapeutic range, or at risk of warfarin-related bleeding complications. We hypo